{"id":"W2947177174","doi":"10.1016/j.dsx.2019.05.034","title":"Residual vascular risk in diabetes – Will the SPPARM alpha concept hold the key?","year":2019,"lang":"en","type":"review","venue":"Diabetes & Metabolic Syndrome Clinical Research & Reviews","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université Laval","funders":"MSD K.K.; Daiichi Sankyo Company; Shionogi; National Institute of Biomedical Innovation; Astellas Pharma; Mochida Pharmaceutical Company; Teijin Pharma; Novo Nordisk; Daiichi-Sankyo; Boehringer Ingelheim Japan; XBiotech; Kowa Pharmaceutical Europe; Takeda Pharmaceuticals U.S.A.; Takeda Pharmaceuticals North America; IFM Therapeutics; Novartis Pharma; Otsuka Pharmaceutical; Bayer Yakuhin; Novartis; AstraZeneca; Amgen; Pfizer; Astellas Pharma US; Kaken Pharmaceutical; Sanofi; Merck","keywords":"Residual; Key (lock); Residual risk; Diabetes mellitus; Alpha (finance); Risk analysis (engineering); Medicine; Computer science; Internal medicine; Endocrinology; Computer security; Surgery; Algorithm","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003537668,0.0008738251,0.003413602,0.00122513,0.0002471108,0.002411145,0.001542945,0.002181145,0.004529823],"category_scores_gemma":[0.003185557,0.0004123232,0.001169246,0.001364059,0.001155266,0.003010814,0.001357798,0.005445546,0.00213066],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006920182,"about_ca_system_score_gemma":0.001929384,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001300745,"about_ca_topic_score_gemma":0.002313086,"domain_scores_codex":[0.9994076,0.0001979042,0.00009261078,0.00007550588,0.0001671659,0.00005919294],"domain_scores_gemma":[0.9981559,0.001260855,0.0001902092,0.00005031858,0.0002544292,0.00008831151],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004001867,0.00008941087,0.0003021767,0.02535205,0.0005196224,0.000119027,0.00008437059,0.0002215006,0.0005051298,0.02104426,0.03689305,0.9144693],"study_design_scores_gemma":[0.0002252329,0.000318159,0.001719758,0.02366519,0.0008517852,0.0006712098,0.0001773304,0.0002159069,0.0002247939,0.02129283,0.9505737,0.00006416733],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004837914,0.9974985,0.00006656594,0.00153957,0.000516792,0.000001623726,0.00001062416,0.000003823225,0.0003141554],"genre_scores_gemma":[0.0007003809,0.9967551,0.0001636552,0.001174222,0.0009059001,0.000005389058,0.00001769038,0.000002126228,0.00027562],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004529823,"threshold_uncertainty_score":0.01870918,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2015271280633693,"score_gpt":0.4693923407127744,"score_spread":0.2678652126494051,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}